1. Home
  2. QNCX vs GAUZ Comparison

QNCX vs GAUZ Comparison

Compare QNCX & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • GAUZ
  • Stock Information
  • Founded
  • QNCX 2012
  • GAUZ 2009
  • Country
  • QNCX United States
  • GAUZ Israel
  • Employees
  • QNCX N/A
  • GAUZ N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • GAUZ Industrial Machinery/Components
  • Sector
  • QNCX Health Care
  • GAUZ Miscellaneous
  • Exchange
  • QNCX Nasdaq
  • GAUZ Nasdaq
  • Market Cap
  • QNCX 90.8M
  • GAUZ 102.0M
  • IPO Year
  • QNCX 2019
  • GAUZ 2024
  • Fundamental
  • Price
  • QNCX $1.60
  • GAUZ $5.72
  • Analyst Decision
  • QNCX Strong Buy
  • GAUZ Strong Buy
  • Analyst Count
  • QNCX 6
  • GAUZ 3
  • Target Price
  • QNCX $8.00
  • GAUZ $13.67
  • AVG Volume (30 Days)
  • QNCX 124.9K
  • GAUZ 62.9K
  • Earning Date
  • QNCX 11-12-2025
  • GAUZ 11-11-2025
  • Dividend Yield
  • QNCX N/A
  • GAUZ N/A
  • EPS Growth
  • QNCX N/A
  • GAUZ N/A
  • EPS
  • QNCX N/A
  • GAUZ N/A
  • Revenue
  • QNCX N/A
  • GAUZ $96,810,000.00
  • Revenue This Year
  • QNCX N/A
  • GAUZ $23.16
  • Revenue Next Year
  • QNCX N/A
  • GAUZ $40.82
  • P/E Ratio
  • QNCX N/A
  • GAUZ N/A
  • Revenue Growth
  • QNCX N/A
  • GAUZ 7.87
  • 52 Week Low
  • QNCX $0.69
  • GAUZ $4.54
  • 52 Week High
  • QNCX $2.45
  • GAUZ $13.00
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 47.89
  • GAUZ 50.06
  • Support Level
  • QNCX $1.56
  • GAUZ $5.19
  • Resistance Level
  • QNCX $1.65
  • GAUZ $5.23
  • Average True Range (ATR)
  • QNCX 0.08
  • GAUZ 0.32
  • MACD
  • QNCX 0.00
  • GAUZ 0.09
  • Stochastic Oscillator
  • QNCX 64.65
  • GAUZ 80.82

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

Share on Social Networks: